Catalyst Wire Dossier Catalyst Wire Dossier

Campath-IH

alemtuzumab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Campath-IH, covering 2012-05-22 to 2012-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies [Phase 2]

See pricing